1. Home
  2. SCLX vs JZ Comparison

SCLX vs JZ Comparison

Compare SCLX & JZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • JZ
  • Stock Information
  • Founded
  • SCLX 2011
  • JZ 2011
  • Country
  • SCLX United States
  • JZ China
  • Employees
  • SCLX N/A
  • JZ N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • JZ Other Consumer Services
  • Sector
  • SCLX Health Care
  • JZ Real Estate
  • Exchange
  • SCLX Nasdaq
  • JZ Nasdaq
  • Market Cap
  • SCLX 28.4M
  • JZ 26.7M
  • IPO Year
  • SCLX N/A
  • JZ 2022
  • Fundamental
  • Price
  • SCLX $4.67
  • JZ $0.40
  • Analyst Decision
  • SCLX Strong Buy
  • JZ
  • Analyst Count
  • SCLX 4
  • JZ 0
  • Target Price
  • SCLX $396.67
  • JZ N/A
  • AVG Volume (30 Days)
  • SCLX 206.3K
  • JZ 2.6M
  • Earning Date
  • SCLX 05-23-2025
  • JZ 01-01-0001
  • Dividend Yield
  • SCLX N/A
  • JZ N/A
  • EPS Growth
  • SCLX N/A
  • JZ N/A
  • EPS
  • SCLX N/A
  • JZ N/A
  • Revenue
  • SCLX $56,590,000.00
  • JZ $34,090,704.00
  • Revenue This Year
  • SCLX $115.30
  • JZ N/A
  • Revenue Next Year
  • SCLX $73.33
  • JZ N/A
  • P/E Ratio
  • SCLX N/A
  • JZ N/A
  • Revenue Growth
  • SCLX 21.07
  • JZ N/A
  • 52 Week Low
  • SCLX $3.60
  • JZ $0.51
  • 52 Week High
  • SCLX $80.50
  • JZ $2.34
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 39.15
  • JZ 29.33
  • Support Level
  • SCLX $3.92
  • JZ $0.41
  • Resistance Level
  • SCLX $6.13
  • JZ $0.70
  • Average True Range (ATR)
  • SCLX 0.69
  • JZ 0.13
  • MACD
  • SCLX 0.13
  • JZ -0.03
  • Stochastic Oscillator
  • SCLX 32.56
  • JZ 1.29

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About JZ Jianzhi Education Technology Group Company Limited

Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.

Share on Social Networks: